[Mechanism of action of an anti-inflammatory steroid on changes in vascular permeability (II). Evaluation of its action as a phospholipase A2 inhibitor].
D000098:Acetophenones / Q000494:pharmacology; D000818:Animals; D016718:Arachidonic Acid; D001095:Arachidonic Acids / Q000494:pharmacology; D002199:Capillary Permeability / Q000187:drug effects*; D002351:Carrageenan / Q000494:pharmacology; D004487:Edema / Q000209:etiology / Q000517:prevention & control; D006854:Hydrocortisone / Q000031:analogs & derivatives* / Q000494:pharmacology; D008297:Male; D051379:Mice; D008813:Mice, Inbred ICR; D010740:Phospholipases / Q000037:antagonists & inhibitors*; D010741:Phospholipases A / Q000037:antagonists & inhibitors*; D054467:Phospholipases A2
D000098:Acetophenones; D001095:Arachidonic Acids; D016718:Arachidonic Acid; C021650:hydrocortisone acetate; D002351:Carrageenan; D010740:Phospholipases; D010741:Phospholipases A; D054467:Phospholipases A2; C006821:4-bromophenacyl bromide; D006854:Hydrocortisone